Formula Growth’s NVIDIA NVDA Stock Holding History

Formula Growth’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-327,040	Closed	-$4.37M	–	160
2021 Q1	$4.37M	Buy	+327,040	New	+$4.4M	0.63%	53

Other funds holding NVDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Formula Growth's NVDA Position: Q2 2021 in Review

Formula Growth sold out of NVIDIA (NVDA) in Q2 2021, closing a stake of 327,040 shares — an estimated $4.37M sold.

Formula Growth first reported a position in NVDA in Q1 2021 and held it in 1 quarter. The position peaked at $4.37M in Q1 2021. 2,514 funds tracked by Wall St. Rank hold NVDA as of Q2 2021.

Formula Growth reported no remaining NVIDIA position as of Q2 2021 after selling out during the quarter.
Formula Growth sold 327,040 NVIDIA shares in Q2 2021, an estimated $4.37M.
Formula Growth first reported a position in NVIDIA in Q1 2021 and held it in 1 quarter.
Formula Growth's NVIDIA position peaked at $4.37M in Q1 2021.
2,514 funds tracked by Wall St. Rank held NVIDIA as of Q2 2021.

Based on Formula Growth's 13F filing for Q2 2021, filed 13 Aug 2021.